2022 · pending · WO2023178264A2
Treatment of HGFAC Related Diseases and Disorders
Gregory McInnes
Compositions comprising oligonucleotides (siRNA or ASO) that target HGFAC for the treatment of cancer and related diseases.
RNA Therapeutics
2022 · pending · WO2023178264A2
Gregory McInnes
Compositions comprising oligonucleotides (siRNA or ASO) that target HGFAC for the treatment of cancer and related diseases.
RNA Therapeutics